Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

409 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vaccine safety controversies and the future of vaccination programs.
François G, Duclos P, Margolis H, Lavanchy D, Siegrist CA, Meheus A, Lambert PH, Emiroğlu N, Badur S, Van Damme P. François G, et al. Among authors: lambert ph. Pediatr Infect Dis J. 2005 Nov;24(11):953-61. doi: 10.1097/01.inf.0000183853.16113.a6. Pediatr Infect Dis J. 2005. PMID: 16282928 Review.
The second Geneva Consensus: Recommendations for novel live TB vaccines.
Walker KB, Brennan MJ, Ho MM, Eskola J, Thiry G, Sadoff J, Dobbelaer R, Grode L, Liu MA, Fruth U, Lambert PH. Walker KB, et al. Among authors: lambert ph. Vaccine. 2010 Mar 8;28(11):2259-70. doi: 10.1016/j.vaccine.2009.12.083. Epub 2010 Jan 20. Vaccine. 2010. PMID: 20074686 Review.
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety.
Folb PI, Bernatowska E, Chen R, Clemens J, Dodoo AN, Ellenberg SS, Farrington CP, John TJ, Lambert PH, Macdonald NE, Miller E, Salisbury D, Schmitt HJ, Siegrist CA, Wimalaratne O. Folb PI, et al. Among authors: lambert ph. Am J Public Health. 2004 Nov;94(11):1926-31. doi: 10.2105/ajph.94.11.1926. Am J Public Health. 2004. PMID: 15514229 Free PMC article.
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 - A Comprehensive Analysis.
Meyer B, Martinez-Murillo PA, Lemaitre B, Blanchard-Rohner G, Didierlaurent AM, Fontannaz P, Eugercios Manzanas C, Lambert PH, Loevy N, Kaiser L, Sartoretti J, Tougne C, Villard J, Huttner A, Siegrist CA, Eberhardt CS. Meyer B, et al. Among authors: lambert ph. Front Immunol. 2022 May 2;13:841009. doi: 10.3389/fimmu.2022.841009. eCollection 2022. Front Immunol. 2022. PMID: 35585978 Free PMC article.
Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis.
Belnoue E, Vogelzang A, Nieuwenhuizen NE, Krzyzaniak MA, Darbre S, Kreutzfeldt M, Wagner I, Merkler D, Lambert PH, Kaufmann SHE, Siegrist CA, Pinschewer DD. Belnoue E, et al. Among authors: lambert ph. Int J Mol Sci. 2022 Feb 28;23(5):2700. doi: 10.3390/ijms23052700. Int J Mol Sci. 2022. PMID: 35269842 Free PMC article.
Novel vaccine safety issues and areas that would benefit from further research.
Salmon DA, Lambert PH, Nohynek HM, Gee J, Parashar UD, Tate JE, Wilder-Smith A, Hartigan-Go KY, Smith PG, Zuber PLF. Salmon DA, et al. Among authors: lambert ph. BMJ Glob Health. 2021 May;6(Suppl 2):e003814. doi: 10.1136/bmjgh-2020-003814. BMJ Glob Health. 2021. PMID: 34011502 Free PMC article. Review.
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Munoz FM, Cramer JP, Dekker CL, Dudley MZ, Graham BS, Gurwith M, Law B, Perlman S, Polack FP, Spergel JM, Van Braeckel E, Ward BJ, Didierlaurent AM, Lambert PH; Brighton Collaboration Vaccine-associated Enhanced Disease Working Group. Munoz FM, et al. Among authors: lambert ph. Vaccine. 2021 May 21;39(22):3053-3066. doi: 10.1016/j.vaccine.2021.01.055. Epub 2021 Feb 23. Vaccine. 2021. PMID: 33637387 Free PMC article. Review.
409 results